UBS maintains Qiagen at 'neutral' with a price target of $48.00

  • Investing.com
UBS maintains Qiagen at 'neutral' with a price target of $48.00

An analyst from UBS maintained Qiagen (NYSE: QGEN ) at 'neutral' with a price target of $48.00 from a prior price target of %currency%%price%.

Prior to this rating, Qiagen had 7 buy ratings, 8 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Qiagen, click here. For more news on Qiagen, click here.

Qiagen's stock price closed at $44.58. They are down -2.69% in the last month and down -10.57% in the last 12 months.

According to Investing Pro, Qiagen's fair value is $47.66, an upside of 6.90%. Qiagen's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Qiagen's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles